drugset / Trial / NCT03912480

Stem Cells From Human Exfoliated Teeth in Treatment of Diabetic Patients With Significantly Reduced Islet Function

NCT03912480 ↗

Phase 0 Unknown 24 enrolled CAR-T (Shanghai) Biotechnology Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the safety and efficacy of Stem cells from human exfoliated teeth transplantation in patients with Islet function decreased significantly to provides scientific basis for further clinical studies to verify the safety and efficacy. On the basis of maintaining the original treatment, intravenous drip of dental pulp mesenchymal stem cells.

Timeline

Start
2019-01-05
Primary completion
2020-12-30
Completion
2021-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Stem Cells From Human Exfoliated Teeth Cell therapy 0.11 iu/kg Intravenous